yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38646051-22C8387B-5089-4B38-B46A-95E012342AD9
Q38646051-22C8387B-5089-4B38-B46A-95E012342AD9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38646051-22C8387B-5089-4B38-B46A-95E012342AD9
Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone.
P2860
Q38646051-22C8387B-5089-4B38-B46A-95E012342AD9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38646051-22C8387B-5089-4B38-B46A-95E012342AD9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
781be3c080ce7945a180d0c4de7758470047742a
P2860
The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis.